We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pozen Submits Vimovo NDA for Osteoarthritis
Pozen Submits Vimovo NDA for Osteoarthritis
September 4, 2009
Pozen will receive a $10 million milestone payment from AstraZeneca because the FDA has accepted the company’s NDA for Vimovo.